Develops medical devices for pain management and wound healing, focusing on ultrasound-based technologies.
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., specializes in developing and distributing noninvasive medical devices designed to activate biological responses for various applications. Established in 2003 and headquartered in Elmsford, New York, NanoVibronix focuses on enhancing healthcare outcomes through innovative technologies.
The company's flagship products include UroShield, an ultrasound-based device that prevents bacterial colonization and biofilm formation in urinary catheters. UroShield also aims to improve antibiotic effectiveness while reducing pain and discomfort associated with catheter use. NanoVibronix also offers PainShield, a patch-based therapeutic ultrasound technology used to manage pain, muscle spasms, and joint contractures. Additionally, WoundShield, another patch-based therapeutic ultrasound device, supports tissue regeneration and accelerates wound healing processes.
NanoVibronix markets its products directly to patients and through distributor agreements across the United States, Israel, Europe, India, and other international markets. With a commitment to advancing noninvasive medical solutions, NanoVibronix continues to innovate in the fields of biofilm prevention, wound care, and pain management, aiming to improve patient comfort and treatment outcomes globally.